Dr. Reddy's Laboratories Limited

03/21/2023 | Press release | Distributed by Public on 03/21/2023 06:17

Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 - Form 6-K

Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

Sub: Allotment of Equity Shares on exercise of Stock Options under ESOPs

This is to inform you that the Nomination, Governance and Compensation Committee of the Board of Directors of the Company has approved the allotment of 1,022 equity shares of Rs. 5/- each of the Company, fully paid up, on March 20, 2023, to employees pursuant to exercise of their Stock Options, as per the following details:

a) 471 equity shares of Rs. 5/- each, pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002.
b) 551 equity shares of Rs.5/- each underlying 551 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.

Further, please find enclosed the details as required under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

This is for your information and records.

Thanking you.

Yours faithfully,

For Dr. Reddy's Laboratories Limited

/s/ K Randhir Singh
K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR

Encl: as above

Details under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

1 Company name and address of Registered Office:
Dr. Reddy's Laboratories Limited
8-2-337, Road No.3, Banjara Hills, Hyderabad - 500034
2

Name of the Stock Exchanges on which the company's shares are listed:
BSE Limited
National Stock Exchange of India Limited
New York Stock Exchange Inc. (ADRs)

NSE IFSC Limited (ADRs)

3

Filing date of the statement referred in Regulation 10(b) of the SEBI (Share Based Employee Benefits) Regulations, 2021 with Stock Exchange:

The Schemes were institutionalised under the erstwhile the SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 and appropriate details under Schedule V were filed. The Schemes comply with provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

4 Filing Number, if any: NA
5 Title of the Scheme pursuant to which shares are issued, if any:
Dr. Reddy's Employees Stock Option Scheme, 2002 and Dr. Reddy's Employees ADR Stock Option Scheme, 2007
6 Kind of security to be listed: Equity Shares
7 Par value of the shares: Rs. 5/-
8 Date of issue of shares: March 20, 2023 (Date of allotment on exercise)
9 Number of shares issued: 1,022 equity shares
10 Share Certificate No., if applicable: NA
11 Distinctive number of the share, if applicable: 212929659 to 212930680
12 ISIN Number of the shares if issued in Demat: INE089A01023
13 Exercise price per share: 1,022 equity shares exercised at Rs. 5/- per share
14 Premium per share: Nil
15 Total Issued shares after this issue: 16,65,28,076(*)
16 Total Issued share capital after this issue: Rs. 83,26,40,380 /-
17 Details of any lock-in on the shares: NA
18 Date of expiry of lock-in: NA
19 Whether shares identical in all respects to existing shares if not, when will they become identical?
Yes, the shares rank pari passu with the existing shares
20 Details of listing fees, if payable: NA

(*) Total paid up capital after this issue: 166,527,876, i.e. Rs. 832,639,380 (difference of 200 due to forfeited shares of Rs. 5/- each in September 1988 on account of non-payment of allotment money.)